IL36RN
protein-codinginterleukin 36 receptor antagonist, the group of Interleukins
Gene summary
The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine was shown to specifically inhibit the activation of NF-kappaB induced by interleukin 1 family, member 6 (IL1F6). This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. Two alternatively spliced transcript variants encoding the same protein have been reported. [provided by RefSeq, Jul 2008]
- IL1F5
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~6.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013626
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013626
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013626
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013626
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0015597
Submitter: Orphanet
Inheritance Pattern: SD
Disease ID:MONDO:0019751
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013626
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013626
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Dermatologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to IL36RN variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_012275.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 38 | 40 | |||
| missense | 2 | 5 | 57 | 6 | 70 | |
| nonsense | 2 | 2 | 4 | |||
| start loss | 0 | |||||
| frameshift | 4 | 3 | 7 | |||
| splice donor/acceptor (+/-2bp) | 3 | 1 | 4 | |||
| Total | 8 | 10 | 63 | 44 | 0 | 125 |
Highest pathogenic variant AF is 0.0033623201
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_036407.1 | 4 | MANE Select | |
| Ensembl | ENSP00000376896.2 | 4 | MANE Select | |
| RefSeq | NP_775262.1 | 4 | Standard | |
| Ensembl | ENSP00000259212.3 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Signaling by Interleukins
- Cytokine Signaling in Immune system
- Immune System
- Interleukin-36 pathway
- Interleukin-1 family signaling
Biological Process
- negative regulation of cytokine-mediated signaling pathway
- inflammatory response
- regulation of signaling receptor activity
- cytokine-mediated signaling pathway
- antifungal humoral response
Molecular Function
- cytokine activity
- interleukin-1 receptor binding
- interleukin-1 receptor antagonist activity
- protein binding
Cellular Component
- extracellular region
- extracellular space
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000393200
- Coding exons
- 4
- Length
- 6745
- Individuals with no LoFs
- 125730
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 18
- Defined
- 125748
- p
- 0.0000716
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.427 | 100 | 88.7 | 1.13 | 0.00000535 | 996 |
| Missense (PolyPhen) | 37 | 33.921 | 1.0908 | 396 | ||
| Synonymous | -0.101 | 41 | 40.2 | 1.02 | 0.00000271 | 318 |
| Loss of Function | -0.858 | 10 | 7.47 | 1.34 | 4.08e-7 | 78 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000088 | 0.000088 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Inhibits the activity of interleukin-36 (IL36A,IL36B and IL36G) by binding to receptor IL1RL2 and preventing its association with the coreceptor IL1RAP for signaling. Part of the IL-36 signaling system that is thought to be present in epithelial barriers and to take part in local inflammatory response; similar to the IL-1 system with which it shares the coreceptor. Proposed to play a role in skin inflammation. May be involved in the innate immune response to fungal pathogens, such as Aspergillus fumigatus. May activate an anti-inflammatory signaling pathway by recruiting SIGIRR. {ECO:0000269|PubMed:11466363, ECO:0000269|PubMed:21965679, ECO:0000269|PubMed:23147407}.;
- Disease
- DISEASE: Psoriasis 14, pustular (PSORS14) [MIM:614204]: A life- threatening disease defined by repeated flares of sudden onset consisting of diffuse erythematous skin eruption characterized by rapid coverage with pustules, high-grade fever, asthenia, marked leukocytosis, and elevated serum levels of C-reactive protein. {ECO:0000269|PubMed:21839423, ECO:0000269|PubMed:21848462, ECO:0000269|PubMed:22903787}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.128
Intolerance Scores
- RVIS EVS
- 0.04
- RVIS percentile EVS
- 56.92
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |